Feb. 15—ROCHESTER — Fueled by $615,000 in state grants, regenerative start-up Rion will soon build out a $7 million Rochester expansion. Rion, founded in 2017 by Mayo Clinic Drs. Andre Terzic and Atta ...
Lonza agreed to provide cGMP manufacturing and technical support for commercial scale production of RION’s Purified Exosome Product™ (PEP) drug substance for late phase clinical supply and beyond.
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company revolutionizing healthcare through its exosome-based technology, announced today that its Co-Founder, Dr. Atta ...
RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, today announced the formation of RION Vet, a veterinary biotechnology company advancing a ...
SPARTANBURG, S.C. -- For 20 years, Danny Holcombe and his wife Sue kept a secret from their son. They never told Rion, who has Down syndrome, that there were some things in life he would never be able ...
ROCHESTER — Rion, Mayo Clinic and the U.S. Army Medical Research Institute for Chemical Defense will use a $2.4 million grant from the U.S. Department of Defense to research treatments for soldiers ...
Rion, founded in Rochester in 2017, plans to build a new manufacturing facility in a 10,000-square-foot space in Building 103 on the Rochester Technology Campus by the end of 2024 or early in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results